STOCK TITAN
  1. Home
  2. News
  3. LH

Labcorp Declares Quarterly Dividend

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
dividends
Rhea-AI Summary
Labcorp declares cash dividend of $0.72 per share of common stock
Positive
  • Labcorp announces cash dividend of $0.72 per share of common stock
Negative
  • None.

BURLINGTON, N.C., Oct. 12, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on December 12, 2023, to stockholders of record as of the close of business on November 8, 2023.

About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's more than 60,000 employees serve clients in over 100 countries, worked on over 80% of the new drugs approved by the FDA in 2022 and performed more than 600 million tests for patients around the world. Learn more about us at www.labcorp.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/labcorp-declares-quarterly-dividend-301954816.html

SOURCE Laboratory Corporation of America Holdings

Labcorp has declared a cash dividend of $0.72 per share of common stock.

The dividend will be payable on December 12, 2023.

The dividend will be paid to stockholders of record as of the close of business on November 8, 2023.
Stock LH logo
Laboratory Corporation of America Holdings

NYSE:LH

LH Rankings

#573 Ranked by Market Cap
#1736 Ranked by Stock Gains
#1641 Ranked by Dividends

LH Latest News

Apr 29, 2024
Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B
Apr 25, 2024
Labcorp Announces 2024 First Quarter Results
Apr 24, 2024
Labcorp Announces Winning Bid for Select Assets of Invitae
Apr 24, 2024
Invitae Enters into Agreement with Labcorp for Sale of Business
Apr 15, 2024
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw

LH Stock Data

16.98B
83.67M
0.34%
98.27%
2.29%
Diagnostic Imaging Centers
Health Care and Social Assistance
Link
United States of America
BURLINGTON

About LH

recognized for our innovation, quality, and customer convenience, labcorp delivers timely, accurate results for improved patient care. with scientific expertise in esoteric testing, genomics, and clinical and anatomic pathology, labcorp performs more than one million tests on approximately 400,000 samples each day. labcorp is a pioneer in applying advances in medicine and science to laboratory testing, with more than 35 years of experience in serving physicians and their patients. labcorp operates a sophisticated laboratory network, with corporate headquarters in burlington, nc, and more than 34,000 employees worldwide. our more than 220,000 clients include physician offices, hospitals, managed care organizations, and biotechnology and pharmaceutical companies. laboratory corporation of america holdings is listed on the new york stock exchange (nyse) under ticker symbol lh.